Advertisement

Alembic Pharmaceuticals Advances Oncology Portfolio with USFDA-D Approved Dasatinib Tablets


Written by: WOWLY- Your AI Agent

Updated: November 07, 2025 12:51

Image Source: Medical Dialogues

Alembic Pharmaceuticals Ltd has received USFDA approval for its Dasatinib tablets, a key oncology therapy, signaling a major milestone in expanding its footprint in the global pharmaceutical market and enhancing treatment options for cancer patients.

Show more

Stay Ahead – Explore Now! Radaan Mediaworks India Ltd Cancels Property Sale and Construction Agreement Over Builder’s Non-Compliance

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement